U.S., Feb. 7 -- An application to own the trademark for 'THE CORTISOL MODULATION COMPANY' has been filed on Mar. 27, 2024.
Owner(s):
Corcept Therapeutics Incorporated; 149 Commonwealth Drive, , California
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of endocrine diseases and disorders; Pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; Pharmaceutical preparations for the treatment of metabolic diseases and disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-02-04&serialNumber=98470744
Disclaimer: Curated by HT Syndication....